New drug trial hopes to slow muscle wasting in rare disease
NCT ID NCT06131983
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 28 times
Summary
This study tests a new medicine called ARO-DUX4 in people with a type of muscular dystrophy (FSHD1) that causes muscle weakness. The goal is to see if the drug is safe and how it works in the body. About 60 adults and teens will receive either the drug or a placebo, and some may continue treatment in a later study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIO-SCAPULO-HUMERAL DYSTROPHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
WITHDRAWNBangkok, 10700, Thailand
-
Research Site 1
RECRUITINGBirtinya, Queensland, 4575, Australia
-
Research Site 1
RECRUITINGMontreal, Quebec, H3A2B4, Canada
-
Research Site 1
RECRUITINGUlm, 89081, Germany
-
Research Site 1
RECRUITINGMilan, 20162, Italy
-
Research Site 1
RECRUITINGLeiden, 2333, Netherlands
-
Research Site 1
RECRUITINGAuckland, 1010, New Zealand
-
Research Site 1
RECRUITINGValencia, 46026, Spain
-
Research Site 2
RECRUITINGLiverpool, New South Wales, 2170, Australia
-
Research Site 2
NOT_YET_RECRUITINGCalgary, Alberta, T2N4Z6, Canada
-
Research Site 2
RECRUITINGMünchen, 80336, Germany
-
Research Site 2
RECRUITINGRoma, 00168, Italy
-
Research Site 2
RECRUITINGMadrid, 28034, Spain
-
Research Site 3
RECRUITINGAuchenflower, Queensland, 4066, Australia
-
Research Site 3
RECRUITINGEdmonton, Alberta, T6G2G4, Canada
-
Research Site 3
RECRUITINGBarcelona, 08035, Spain
-
Research Site 4
RECRUITINGMelbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.